Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10-1074 in HIV-infected and HIV-uninfected individuals
NCT02511990Phase 1Completed
- Sponsor
- The Rockefeller University
- Start
- Jul 2015
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
Phase 1, open-label trial of zinlirvimab in human immunodeficiency virus infection (HIV), sponsored by The Rockefeller University. Started Jul 2015; status: completed.
02
Drugs
zinlirvimab
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02511990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02511990.